Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease
- PMID: 11083826
- PMCID: PMC97811
- DOI: 10.1128/IAI.68.12.7010-7017.2000
Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease
Abstract
Initiation and perpetuation of the inflammatory intestinal responses in inflammatory bowel disease (IBD) may result from an exaggerated host defense reaction of the intestinal epithelium to endogenous lumenal bacterial flora. Intestinal epithelial cell lines constitutively express several functional Toll-like receptors (TLRs) which appear to be key regulators of the innate response system. The aim of this study was to characterize the expression pattern of TLR2, TLR3, TLR4, and TLR5 in primary intestinal epithelial cells from patients with IBD. Small intestinal and colonic biopsy specimens were collected from patients with IBD (Crohn's disease [CD], ulcerative colitis [UC]) and controls. Non-IBD specimens were assessed by immunofluorescence histochemistry using polyclonal antibodies specific for TLR2, TLR3, TLR4, and TLR5. Primary intestinal epithelial cells (IEC) of normal mucosa constitutively expressed TLR3 and TLR5, while TLR2 and TLR4 were only barely detectable. In active IBD, the expression of TLR3 and TLR4 was differentially modulated in the intestinal epithelium. TLR3 was significantly downregulated in IEC in active CD but not in UC. In contrast, TLR4 was strongly upregulated in both UC and CD. TLR2 and TLR5 expression remained unchanged in IBD. These data suggest that IBD may be associated with distinctive changes in selective TLR expression in the intestinal epithelium, implying that alterations in the innate response system may contribute to the pathogenesis of these disorders.
Figures
Similar articles
-
The expression patterns of Toll-like receptors in the ileal pouch mucosa of postoperative ulcerative colitis patients.Surg Today. 2006;36(3):287-90. doi: 10.1007/s00595-005-3144-y. Surg Today. 2006. PMID: 16493544
-
Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease.Clin Exp Immunol. 2008 Jan;151(1):34-41. doi: 10.1111/j.1365-2249.2007.03531.x. Epub 2007 Nov 7. Clin Exp Immunol. 2008. PMID: 17991289 Free PMC article.
-
Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.Dan Med J. 2015 Jan;62(1):B4973. Dan Med J. 2015. PMID: 25557335 Review.
-
Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?Clin Exp Immunol. 2016 Mar;183(3):358-68. doi: 10.1111/cei.12732. Epub 2015 Nov 26. Clin Exp Immunol. 2016. PMID: 26462859 Free PMC article.
-
Toll-like receptor family and signalling pathway.Biochem Soc Trans. 2000 Oct;28(5):563-6. doi: 10.1042/bst0280563. Biochem Soc Trans. 2000. PMID: 11044375 Review.
Cited by
-
Cellular and molecular mechanisms of intestinal fibrosis.World J Gastroenterol. 2012 Jul 28;18(28):3635-61. doi: 10.3748/wjg.v18.i28.3635. World J Gastroenterol. 2012. PMID: 22851857 Free PMC article.
-
The dual role of inflammation in colon carcinogenesis.Int J Mol Sci. 2012;13(9):11071-11084. doi: 10.3390/ijms130911071. Epub 2012 Sep 6. Int J Mol Sci. 2012. PMID: 23109839 Free PMC article. Review.
-
Toll-like receptor 4 (TLR4) antagonists as potential therapeutics for intestinal inflammation.Indian J Gastroenterol. 2021 Feb;40(1):5-21. doi: 10.1007/s12664-020-01114-y. Epub 2021 Mar 5. Indian J Gastroenterol. 2021. PMID: 33666891 Free PMC article. Review.
-
A critical role for TLR4 induction of autophagy in the regulation of enterocyte migration and the pathogenesis of necrotizing enterocolitis.J Immunol. 2013 Apr 1;190(7):3541-51. doi: 10.4049/jimmunol.1202264. Epub 2013 Mar 1. J Immunol. 2013. PMID: 23455503 Free PMC article.
-
Expression of Toll-like receptor-3 is enhanced in active inflammatory bowel disease and mediates the excessive release of lipocalin 2.Clin Exp Immunol. 2013 Sep;173(3):502-11. doi: 10.1111/cei.12136. Clin Exp Immunol. 2013. PMID: 23668802 Free PMC article.
References
-
- Akashi S, Ogata H, Kirikae F, Kirikae T, Kawasaki K, Nishijima M, Shimazu R, Nagai Y, Fukudome K, Kimoto M, et al. Regulatory roles for CD14 and phosphatidylinositol in the signaling via toll-like receptor 4-MD-2. Biochem Biophys Res Commun. 2000;268:172–177. - PubMed
-
- Awane M, Andres P G, Li D J, Reinecker H C. NF-kB-inducing kinase is a common mediator of IL-17-, TNFa-, and IL-1β-induced chemokine promoter activation in intestinal epithelial cells. J Immunol. 1999;162:5337–5344. - PubMed
-
- Beutler B. Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol. 2000;12:20–26. - PubMed
-
- Bhan A, Mizoguchi E, Smith R N, Mizoguchi A. Colitis in transgenic and knockout animals as models of human inflammatory bowel disease. Immunol Rev. 1999;169:195–207. - PubMed
-
- Cario E, Rosenberg I M, Brandwein S L, Beck P L, Reinecker H C, Podolsky D K. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol. 2000;164:966–972. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
